Table 3.

Baseline characteristics and predicted outcomes of the patient with median risk from each quintile of predicted risk of transition two

		Patient A (Q1)	Patient B (Q2)	Patient C (Q3)	Patient D (Q4)	Patient E (Q5)
Age (yrs)		66	64	69	65	75
Gender (M/F)		M	M	F	M	M
NYHA Class (II or III)		II	II	III	II	III
LVEF (%)		38	35	30	29	31
Creatinine (mg/dl)		1.6	2.0	0.7	1.2	1.1
Serum sodium (mEq/L)		141	135	141	140	135
Systolic blood pressure (mmHg)		152	160	122	140	115
Weight (kg)		110	115	84.3	78	105
Diabetes (Y/N)		−	−	+	+	+
Ischemic etiology (Y/N)		−	+	+	+	+
Atrial fibrillation (Y/N)		−	−	−	−	+
Prior stroke (Y/N)		−	−	−	−	−
1 yr probabilities of being in a given outcome state	Alive without HFH	94.3%	91.9%	89.0%	87.1%	77.1%
	HFH, still alive	3.6%	4.6%	6.1%	6.3%	12.5%
	Death without HFH	1.9%	3.0%	4.1%	5.7%	8.5%
	HFH followed by death	0.2%	0.5%	0.8%	0.9%	1.9%
3 yr probabilities of being in a given outcome state	Alive without HFH	84.9%	78.8%	72.0%	67.3%	48.0%
	HFH, still alive	7.8%	9.3%	11.1%	11.1%	19.4%
	Death without HFH	5.7%	8.9%	11.7%	15.9%	11.0%
	HFH followed by death	1.6%	3.0%	5.2%	5.7%	21.6%
6 yr probabilities of being in a given outcome state	Alive without HFH	72.5%	62.5%	52.3%	45.4%	23.4%
	HFH, still alive	10.7%	11.1%	11.5%	10.6%	15.5%
	Death without HFH	11.4%	16.8%	21.3%	28.1%	33.7%
	HFH followed by death	5.4%	9.6%	14.9%	15.9%	27.4%

Q1 refers to quintile 1 (lowest risk), Q2 quintile 2, Q3 quintile 3, Q4 quintile 4, Q5 quintile 5 (highest risk), M male, F female, NYHA New York Heart Association, LVEF left ventricular ejection fraction, HFH heart failure hospitalization, (+) refers to present and (−) refers to absent at baseline